Advertisement
Screener

Exelixis Inc (EXEL) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

Exelixis Inc Increase (Decrease) in Prepaid Expense and Other Assets

Exelixis Inc (EXEL) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$99.16 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05

  • Exelixis Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-07-03 was -$40.50M, a 138.68% decline year-over-year.
  • Exelixis Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-04-03 was -$58.65M.
  • Exelixis Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-01-02 was $97.03M.
  • Exelixis Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-10-03 was -$47.65M, a 149.26% decline year-over-year.
  • Exelixis Inc increase (decrease) in prepaid expense and other assets for fiscal 2026 was $133.77M.
  • Exelixis Inc increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$31.08M, a 204.21% decline from fiscal 2023.
  • Exelixis Inc increase (decrease) in prepaid expense and other assets for fiscal 2023 was $29.82M, a 5.54% increase from fiscal 2022.
  • Exelixis Inc increase (decrease) in prepaid expense and other assets for fiscal 2022 was $28.26M, a 29.13% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-07-03-$40.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$99.16M
10-Q · filed 2026-08-05
-$2.12M
derived: sum of 3 quarters · filed 2026-08-05
-$49.77M
derived: sum of 4 quarters · filed 2026-08-05
2026-04-03-$58.65M
10-Q · filed 2026-05-05
$38.38M
derived: sum of 2 quarters · filed 2026-05-05
-$9.27M
derived: sum of 3 quarters · filed 2026-05-05
$95.44M
derived: sum of 4 quarters · filed 2026-08-05
2026-01-02$97.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
$49.38M
derived: sum of 2 quarters · filed 2026-02-10
$154.09M
derived: sum of 3 quarters · filed 2026-08-05
$133.77M
10-K · filed 2026-02-10
2025-10-03-$47.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$57.06M
derived: sum of 2 quarters · filed 2026-08-05
$36.74M
10-Q · filed 2025-11-04
-$57.41M
derived: sum of 4 quarters · filed 2026-08-05
2025-07-04$104.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$84.39M
10-Q · filed 2026-08-05
-$9.76M
derived: sum of 3 quarters · filed 2026-08-05
$86.97M
derived: sum of 4 quarters · filed 2026-08-05
2025-04-04-$20.32M
10-Q · filed 2026-05-05
-$114.47M
derived: sum of 2 quarters · filed 2026-05-05
-$17.74M
derived: sum of 3 quarters · filed 2026-05-05
-$41.32M
derived: sum of 4 quarters · filed 2026-05-05
2025-01-03-$94.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
$2.58M
derived: sum of 2 quarters · filed 2026-02-10
-$21.00M
derived: sum of 3 quarters · filed 2026-02-10
-$31.08M
10-K · filed 2026-02-10
2024-09-27$96.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$73.14M
derived: sum of 2 quarters · filed 2025-11-04
$63.07M
10-Q · filed 2025-11-04
$95.32M
derived: sum of 4 quarters · filed 2026-02-10
2024-06-28-$23.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-28
-$33.66M
10-Q · filed 2025-07-28
-$1.41M
derived: sum of 3 quarters · filed 2026-02-10
$4.71M
derived: sum of 4 quarters · filed 2026-02-10
2024-03-29-$10.07M
10-Q · filed 2025-05-13
$22.18M
derived: sum of 2 quarters · filed 2026-02-10
$28.30M
derived: sum of 3 quarters · filed 2026-02-10
$30.12M
derived: sum of 4 quarters · filed 2026-02-10
2023-12-29$32.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
$38.37M
derived: sum of 2 quarters · filed 2026-02-10
$40.20M
derived: sum of 3 quarters · filed 2026-02-10
$29.82M
10-K · filed 2026-02-10
2023-09-29$6.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$7.94M
derived: sum of 2 quarters · filed 2024-10-29
-$2.43M
10-Q · filed 2024-10-29
-$9.34M
derived: sum of 4 quarters · filed 2025-02-11
2023-06-30$1.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$8.55M
10-Q · filed 2024-08-06
-$15.46M
derived: sum of 3 quarters · filed 2025-02-11
-$6.31M
derived: sum of 4 quarters · filed 2025-02-11
2023-03-31-$10.37M
10-Q · filed 2024-04-30
-$17.28M
derived: sum of 2 quarters · filed 2025-02-11
-$8.14M
derived: sum of 3 quarters · filed 2025-02-11
$14.28M
derived: sum of 4 quarters · filed 2025-02-11
2022-12-30-$6.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11
$2.23M
derived: sum of 2 quarters · filed 2025-02-11
$24.65M
derived: sum of 3 quarters · filed 2025-02-11
$28.26M
10-K · filed 2025-02-11
2022-09-30$9.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$31.56M
derived: sum of 2 quarters · filed 2023-11-01
$35.17M
10-Q · filed 2023-11-01
$50.79M
derived: sum of 4 quarters · filed 2024-02-06
2022-07-01$22.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$26.02M
10-Q · filed 2023-08-01
$41.65M
derived: sum of 3 quarters · filed 2024-02-06
$53.60M
derived: sum of 4 quarters · filed 2024-02-06
2022-04-01$3.60M
10-Q · filed 2023-05-09
$19.23M
derived: sum of 2 quarters · filed 2024-02-06
$31.18M
derived: sum of 3 quarters · filed 2024-02-06
$45.35M
derived: sum of 4 quarters · filed 2024-02-06
2021-12-31$15.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06
$27.58M
derived: sum of 2 quarters · filed 2024-02-06
$41.75M
derived: sum of 3 quarters · filed 2024-02-06
$39.88M
10-K · filed 2024-02-06
2021-10-01$11.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$26.12M
derived: sum of 2 quarters · filed 2022-11-01
$24.25M
10-Q · filed 2022-11-01
$34.22M
derived: sum of 4 quarters · filed 2023-02-07
2021-07-02$14.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$12.30M
10-Q · filed 2022-08-09
$22.26M
derived: sum of 3 quarters · filed 2023-02-07
$19.17M
derived: sum of 4 quarters · filed 2023-02-07
2021-04-02-$1.87M
10-Q · filed 2022-05-10
$8.09M
derived: sum of 2 quarters · filed 2023-02-07
$5.00M
derived: sum of 3 quarters · filed 2023-02-07
$21.10M
derived: sum of 4 quarters · filed 2023-02-07
2021-01-01$9.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07
$6.88M
derived: sum of 2 quarters · filed 2023-02-07
$22.97M
derived: sum of 3 quarters · filed 2023-02-07
$25.83M
10-K · filed 2023-02-07
2020-10-02-$3.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
$13.01M
derived: sum of 2 quarters · filed 2021-11-02
$15.87M
10-Q · filed 2021-11-02
$7.48M
derived: sum of 4 quarters · filed 2022-02-18
2020-07-03$16.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$18.95M
10-Q · filed 2021-08-05
$10.57M
derived: sum of 3 quarters · filed 2022-02-18
$15.40M
derived: sum of 4 quarters · filed 2022-02-18
2020-04-03$2.86M
10-Q · filed 2021-05-06
-$5.52M
derived: sum of 2 quarters · filed 2022-02-18
-$692.00K
derived: sum of 3 quarters · filed 2022-02-18
-$2.58M
derived: sum of 4 quarters · filed 2022-02-18
2020-01-03-$8.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
-$3.56M
derived: sum of 2 quarters · filed 2022-02-18
-$5.44M
derived: sum of 3 quarters · filed 2022-02-18
$5.72M
10-K · filed 2022-02-18
2019-09-27$4.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$2.94M
derived: sum of 2 quarters · filed 2020-11-05
$14.11M
10-Q · filed 2020-11-05
-$527.00K
10-Q · filed 2019-10-30
$19.10M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-28-$1.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$9.28M
10-Q · filed 2020-08-06
-$2.17M
10-Q · filed 2019-07-31
$14.27M
derived: sum of 3 quarters · filed 2020-08-06
$16.23M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-29$11.16M
10-Q · filed 2020-05-05
-$871.00K
10-Q · filed 2019-05-01
$16.16M
derived: sum of 2 quarters · filed 2020-05-05
$18.11M
derived: sum of 3 quarters · filed 2020-05-05
$21.59M
derived: sum of 4 quarters · filed 2020-05-05
2018-12-28$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$6.95M
derived: sum of 2 quarters · filed 2020-02-25
$10.43M
derived: sum of 3 quarters · filed 2020-02-25
$8.53M
10-K · filed 2021-02-11
2018-09-28$1.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$5.43M
derived: sum of 2 quarters · filed 2019-10-30
$3.53M
10-Q · filed 2019-10-30
$1.38M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-29$3.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$1.58M
10-Q · filed 2019-07-31
-$575.00K
derived: sum of 3 quarters · filed 2020-02-25
$3.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-30-$1.90M
10-Q · filed 2019-05-01
-$4.05M
derived: sum of 2 quarters · filed 2020-02-25
-$473.00K
derived: sum of 3 quarters · filed 2020-02-25
2017-12-29-$2.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$1.43M
derived: sum of 2 quarters · filed 2020-02-25
$378.00K
10-K · filed 2020-02-25
$3.27M
10-K · filed 2018-02-26
2017-09-30$3.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
$2.53M
10-Q · filed 2017-11-01
2017-09-29$3.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$1.65M
derived: sum of 2 quarters · filed 2018-11-01
$2.53M
10-Q · filed 2018-11-01
$798.00K
derived: sum of 4 quarters · filed 2018-11-01
2017-06-30-$1.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$1.05M
10-Q · filed 2017-08-02
-$2.78M
derived: sum of 3 quarters · filed 2018-05-02
-$290.00K
derived: sum of 4 quarters · filed 2018-05-02
2017-03-31$881.00K
10-Q · filed 2017-05-01
-$851.00K
derived: sum of 2 quarters · filed 2018-05-02
$1.64M
derived: sum of 3 quarters · filed 2018-05-02
$1.51M
derived: sum of 4 quarters · filed 2018-05-02
2016-12-31-$1.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$759.00K
derived: sum of 2 quarters · filed 2017-11-01
$625.00K
derived: sum of 3 quarters · filed 2017-11-01
$1.61M
10-K · filed 2017-02-27
2016-12-30$1.61M
10-K · filed 2019-02-22
2016-09-30$2.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
$2.36M
derived: sum of 2 quarters · filed 2017-11-01
$3.34M
10-Q · filed 2017-11-01
$1.73M
derived: sum of 4 quarters · filed 2017-11-01
2016-06-30-$134.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$851.00K
10-Q · filed 2017-08-02
-$764.00K
derived: sum of 3 quarters · filed 2017-08-02
$1.93M
derived: sum of 4 quarters · filed 2017-08-02
2016-03-31$985.00K
10-Q · filed 2017-05-01
-$630.00K
derived: sum of 2 quarters · filed 2017-05-01
$2.06M
derived: sum of 3 quarters · filed 2017-05-01
-$421.00K
derived: sum of 4 quarters · filed 2017-05-01
2016-01-01$325.00K
10-K · filed 2018-02-26
2015-12-31-$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$1.08M
derived: sum of 2 quarters · filed 2017-02-27
-$1.41M
derived: sum of 3 quarters · filed 2017-02-27
$325.00K
10-K · filed 2017-02-27
2015-09-30$2.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$209.00K
derived: sum of 2 quarters · filed 2016-11-03
$1.94M
10-Q · filed 2016-11-03
$108.00K
10-Q · filed 2015-11-10
-$2.42M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$2.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
-$751.00K
10-Q · filed 2016-08-03
-$953.00K
10-Q · filed 2015-08-11
-$5.11M
derived: sum of 3 quarters · filed 2017-02-27
-$2.05M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31$1.73M
10-Q · filed 2016-05-04
$1.85M
10-Q · filed 2015-04-30
-$2.63M
derived: sum of 2 quarters · filed 2017-02-27
$431.00K
derived: sum of 3 quarters · filed 2017-02-27
-$159.00K
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31-$4.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$1.30M
derived: sum of 2 quarters · filed 2017-02-27
-$1.89M
derived: sum of 3 quarters · filed 2017-02-27
-$1.53M
10-K · filed 2017-02-27
2014-09-30$3.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
$2.47M
derived: sum of 2 quarters · filed 2015-11-10
$2.83M
10-Q · filed 2015-11-10
$305.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$590.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11
-$226.00K
10-Q · filed 2015-08-11
-$2.75M
derived: sum of 3 quarters · filed 2016-02-29
-$1.04M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$364.00K
10-Q · filed 2015-04-30
$359.00K
10-Q · filed 2014-05-01
-$2.17M
derived: sum of 2 quarters · filed 2016-02-29
-$446.00K
derived: sum of 3 quarters · filed 2016-02-29
-$5.43M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$2.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$810.00K
derived: sum of 2 quarters · filed 2016-02-29
-$5.79M
derived: sum of 3 quarters · filed 2016-02-29
-$1.03M
10-K · filed 2016-02-29
2013-09-30$1.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04
-$3.26M
derived: sum of 2 quarters · filed 2014-11-04
$1.50M
10-Q · filed 2014-11-04
$1.37M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$4.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
-$224.00K
10-Q · filed 2014-07-31
-$352.00K
derived: sum of 3 quarters · filed 2015-03-02
$1.29M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$4.76M
10-Q · filed 2014-05-01
$4.63M
derived: sum of 2 quarters · filed 2015-03-02
$6.27M
derived: sum of 3 quarters · filed 2015-03-02
$6.25M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$128.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$1.51M
derived: sum of 2 quarters · filed 2015-03-02
$1.50M
derived: sum of 3 quarters · filed 2015-03-02
$1.76M
10-K · filed 2015-03-02
2012-09-30$1.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$1.62M
derived: sum of 2 quarters · filed 2013-10-30
$1.89M
10-Q · filed 2013-10-30
-$10.18M
derived: sum of 4 quarters · filed 2014-02-20
2012-06-30-$14.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$254.00K
10-Q · filed 2013-08-06
-$11.82M
derived: sum of 3 quarters · filed 2014-02-20
-$9.81M
derived: sum of 4 quarters · filed 2014-02-20
2012-03-31$268.00K
10-Q · filed 2013-05-07
-$11.81M
derived: sum of 2 quarters · filed 2014-02-20
-$9.80M
derived: sum of 3 quarters · filed 2014-02-20
-$11.56M
derived: sum of 4 quarters · filed 2014-02-20
2011-12-31-$12.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
-$10.07M
derived: sum of 2 quarters · filed 2014-02-20
-$11.83M
derived: sum of 3 quarters · filed 2014-02-20
-$10.55M
10-K · filed 2014-02-20
2011-09-30$2.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
$243.00K
derived: sum of 2 quarters · filed 2012-11-07
$1.52M
10-Q · filed 2012-11-07
-$1.37M
derived: sum of 4 quarters · filed 2013-02-21
2011-06-30-$1.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
-$485.00K
10-Q · filed 2012-08-02
-$3.38M
derived: sum of 3 quarters · filed 2013-02-21
-$1.85M
derived: sum of 4 quarters · filed 2013-02-21
2011-03-31$1.28M
10-Q · filed 2012-05-03
-$1.61M
derived: sum of 2 quarters · filed 2013-02-21
-$84.00K
derived: sum of 3 quarters · filed 2013-02-21
2010-12-31-$2.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
-$1.36M
derived: sum of 2 quarters · filed 2013-02-21
$66.00K
10-K · filed 2013-02-21
2010-09-30$1.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27
$2.96M
10-Q · filed 2011-10-27
2010-06-30$1.43M
10-Q · filed 2011-08-04
2009-12-31$7.34M
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78